{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T05:09:52Z","timestamp":1675573792850},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00347-023-01814-8","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T15:04:05Z","timestamp":1674659045000},"page":"223-236","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assoziation der verschiedenen Uveitisformen mit entz\u00fcndlich rheumatischen Erkrankungen und ihre Therapie"],"prefix":"10.1007","volume":"120","author":[{"given":"Nicole","family":"St\u00fcbiger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Farrokhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannik","family":"Gkanatsas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Deuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"K\u00f6tter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"1814_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1750-1172-7-57","volume":"7","author":"T Barisani-Asenbauer","year":"2012","unstructured":"Barisani-Asenbauer\u00a0T, Maca\u00a0SM, Mejdoubi\u00a0L et al (2012) Uveitis\u2014a\u00a0rare disease often associated with systemic diseases and infections\u2014a\u00a0systematic review of 2619\u00a0patients. Orphanet J Rare Dis 7:57","journal-title":"Orphanet J Rare Dis"},{"key":"1814_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3899\/jrheum.080102","volume":"36","author":"E Jakob","year":"2009","unstructured":"Jakob\u00a0E, Reuland\u00a0MS, Mackensen\u00a0F et\u00a0al (2009) Uveitis subtypes in a\u00a0german interdisciplinary uveitis center\u2014analysis of 1916\u00a0patients. J\u00a0Rheumatol 36:127\u2013136","journal-title":"J Rheumatol"},{"key":"1814_CR3","doi-asserted-by":"publisher","first-page":"1759720X2095173","DOI":"10.1177\/1759720X20951733","volume":"12","author":"J Rademacher","year":"2020","unstructured":"Rademacher\u00a0J, Poddubnyy\u00a0D, Pleyer\u00a0U (2020) Uveitis in spondyloarthritis. Ther Adv Musculoskelet Dis 12:1759720X20951733","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"1814_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/ard.2007.075754","volume":"67","author":"N Zeboulon","year":"2008","unstructured":"Zeboulon\u00a0N, Dougados\u00a0M, Gossec\u00a0L (2008) Prevalence and characteristics of uveitis in the spondyloarthropathies: a\u00a0systematic literature review. Ann Rheum Dis 67:955\u2013959","journal-title":"Ann Rheum Dis"},{"key":"1814_CR5","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.3899\/jrheum.170036","volume":"44","author":"TL Oliveira","year":"2017","unstructured":"Oliveira\u00a0TL, Maksymowych\u00a0WP, Lambert\u00a0RGW et al (2017) Sacroiliac joint magnetic resonance imaging in asymptomatic patients with recurrent acute anterior uveitis: a proof-of-concept study. J\u00a0Rheumatol 44:1833\u20131840","journal-title":"J Rheumatol"},{"key":"1814_CR6","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1136\/annrheumdis-2014-205358","volume":"74","author":"M Haroon","year":"2015","unstructured":"Haroon\u00a0M, O\u2019rourke\u00a0M, Ramasamy\u00a0P et al (2015) A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool). Ann Rheum Dis 74:1990\u20131995","journal-title":"Ann Rheum Dis"},{"key":"1814_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/09273940902818861","volume":"17","author":"CP Herbort","year":"2009","unstructured":"Herbort\u00a0CP, Rao\u00a0NA, Mochizuki\u00a0M (2009) International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm 17:160\u2013169","journal-title":"Ocul Immunol Inflamm"},{"key":"1814_CR8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.autrev.2014.04.001","volume":"13","author":"Y Jamilloux","year":"2014","unstructured":"Jamilloux\u00a0Y, Kodjikian\u00a0L, Broussolle\u00a0C et\u00a0al (2014) Sarcoidosis and uveitis. Autoimmun Rev 13:840\u2013849","journal-title":"Autoimmun Rev"},{"key":"1814_CR9","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","volume":"103","author":"M Mochizuki","year":"2019","unstructured":"Mochizuki\u00a0M, Smith\u00a0JR, Takase\u00a0H et\u00a0al (2019) Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol 103:1418\u20131422","journal-title":"Br J Ophthalmol"},{"key":"1814_CR10","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1055\/s-0042-104063","volume":"233","author":"K Walscheid","year":"2016","unstructured":"Walscheid\u00a0K, Tappeiner\u00a0C, Heiligenhaus\u00a0A (2016) Ocular Manifestations in Sarcoidosis. Klin Monbl Augenheilkd 233:594\u2013600","journal-title":"Klin Monbl Augenheilkd"},{"key":"1814_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00347-017-0552-5","volume":"114","author":"E Gundlach","year":"2017","unstructured":"Gundlach\u00a0E, Temmesfeld-Wollbruck\u00a0B, Pleyer\u00a0U (2017) Ocular sarcoidosis : Diagnosis and therapy. Ophthalmologe 114:865\u2013876","journal-title":"Ophthalmologe"},{"key":"1814_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00393-017-0303-7","volume":"76","author":"C Springer-Wanner","year":"2017","unstructured":"Springer-Wanner\u00a0C, Brauns\u00a0T (2017) Ocular sarcoidosis. Z\u00a0Rheumatol 76:391\u2013397","journal-title":"Z Rheumatol"},{"key":"1814_CR13","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/j.lpm.2012.04.004","volume":"41","author":"B Bodaghi","year":"2012","unstructured":"Bodaghi\u00a0B, Touitou\u00a0V, Fardeau\u00a0C et\u00a0al (2012) Ocular sarcoidosis. Presse Med 41:e349\u2013354","journal-title":"Presse Med"},{"key":"1814_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/bjo.84.1.110","volume":"84","author":"A Rothova","year":"2000","unstructured":"Rothova\u00a0A (2000) Ocular involvement in sarcoidosis. Br J Ophthalmol 84:110\u2013116","journal-title":"Br J Ophthalmol"},{"key":"1814_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nrrheum.2018.3","volume":"14","author":"H Yazici","year":"2018","unstructured":"Yazici\u00a0H, Seyahi\u00a0E, Hatemi\u00a0G et\u00a0al (2018) Behcet syndrome: a\u00a0contemporary view. Nat Rev Rheumatol 14:119","journal-title":"Nat Rev Rheumatol"},{"key":"1814_CR16","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1136\/bjo.2007.123554","volume":"91","author":"N Kitaichi","year":"2007","unstructured":"Kitaichi\u00a0N, Miyazaki\u00a0A, Iwata\u00a0D et\u00a0al (2007) Ocular features of Behcet\u2019s disease: an international collaborative study. Br J Ophthalmol 91:1579\u20131582","journal-title":"Br J Ophthalmol"},{"key":"1814_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00004397-200604620-00017","volume":"46","author":"PA Yates","year":"2006","unstructured":"Yates\u00a0PA, Michelson\u00a0JB (2006) Behcet disease. Int Ophthalmol Clin 46:209\u2013233","journal-title":"Int Ophthalmol Clin"},{"key":"1814_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/09273948.2015.1094095","volume":"25","author":"M Accorinti","year":"2017","unstructured":"Accorinti\u00a0M, Pesci\u00a0FR, Pirraglia\u00a0MP et al (2017) Ocular Behcet\u2019s disease: changing patterns over time, complications and long-term visual prognosis. Ocul Immunol Inflamm 25:29\u201336","journal-title":"Ocul Immunol Inflamm"},{"key":"1814_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13075-021-02429-7","volume":"23","author":"J Zou","year":"2021","unstructured":"Zou\u00a0J, Luo\u00a0JF, Shen\u00a0Y et\u00a0al (2021) Cluster analysis of phenotypes of patients with Behcet\u2019s syndrome: a\u00a0large cohort study from a\u00a0referral center in China. Arthritis Res Ther 23:45","journal-title":"Arthritis Res Ther"},{"key":"1814_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.semarthrit.2012.08.003","volume":"42","author":"PR Rothschild","year":"2013","unstructured":"Rothschild\u00a0PR, Pagnoux\u00a0C, Seror\u00a0R et\u00a0al (2013) Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a\u00a0retrospective study of 1286\u00a0patients and review of the literature. Semin Arthritis Rheum 42:507\u2013514","journal-title":"Semin Arthritis Rheum"},{"key":"1814_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3899\/jrheum.190768","volume":"48","author":"MA Turk","year":"2021","unstructured":"Turk\u00a0MA, Hayworth\u00a0JL, Nevskaya\u00a0T et\u00a0al (2021) Ocular manifestations in rheumatoid arthritis, connective tissue disease, and vasculitis: a systematic review and metaanalysis. J\u00a0Rheumatol 48:25\u201334","journal-title":"J Rheumatol"},{"key":"1814_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s40123-019-0176-8","volume":"8","author":"E Sfiniadaki","year":"2019","unstructured":"Sfiniadaki\u00a0E, Tsiara\u00a0I, Theodossiadis\u00a0P et\u00a0al (2019) Ocular manifestations of granulomatosis with polyangiitis: a review of the literature. Ophthalmol Ther 8:227\u2013234","journal-title":"Ophthalmol Ther"},{"key":"1814_CR23","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/bjophthalmol-2015-307460","volume":"100","author":"L Cocho","year":"2016","unstructured":"Cocho\u00a0L, Gonzalez-Gonzalez\u00a0LA, Molina-Prat\u00a0N et al (2016) Scleritis in patients with granulomatosis with polyangiitis (Wegener). Br J Ophthalmol 100:1062\u20131065","journal-title":"Br J Ophthalmol"},{"key":"1814_CR24","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.3899\/jrheum.121473","volume":"40","author":"PC Grayson","year":"2013","unstructured":"Grayson\u00a0PC, Cuthbertson\u00a0D, Carette\u00a0S et\u00a0al (2013) New features of disease after diagnosis in 6 forms of systemic vasculitis. J\u00a0Rheumatol 40:1905\u20131912","journal-title":"J Rheumatol"},{"key":"1814_CR25","first-page":"111","volume":"3","author":"MM Moschos","year":"2009","unstructured":"Moschos\u00a0MM, Guex-Crosier\u00a0Y (2009) Giant cell arteritis: a rare cause of posterior vasculitis. Clin Ophthalmol 3:111\u2013115","journal-title":"Clin Ophthalmol"},{"key":"1814_CR26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3899\/jrheum.170437","volume":"45","author":"C Caimmi","year":"2018","unstructured":"Caimmi\u00a0C, Crowson\u00a0CS, Smith\u00a0WM et\u00a0al (2018) Clinical correlates, outcomes, and predictors of inflammatory ocular disease associated with rheumatoid arthritis in the biologic era. J\u00a0Rheumatol 45:595\u2013603","journal-title":"J Rheumatol"},{"key":"1814_CR27","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/art.41709","volume":"73","author":"T Braithwaite","year":"2021","unstructured":"Braithwaite\u00a0T, Adderley\u00a0NJ, Subramanian\u00a0A et al (2021) Epidemiology of scleritis in the United Kingdom from 1997 to 2018: population-based analysis of 11 million patients and association between scleritis and infectious and immune-mediated inflammatory disease. Arthritis Rheumatol 73:1267\u20131276","journal-title":"Arthritis Rheumatol"},{"key":"1814_CR28","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nrrheum.2014.85","volume":"10","author":"L Tong","year":"2014","unstructured":"Tong\u00a0L, Thumboo\u00a0J, Tan\u00a0YK et\u00a0al (2014) The eye: a\u00a0window of opportunity in rheumatoid arthritis? Nat Rev Rheumatol 10:552\u2013560","journal-title":"Nat Rev Rheumatol"},{"key":"1814_CR29","first-page":"393","volume":"9","author":"AP Vignesh","year":"2015","unstructured":"Vignesh\u00a0AP, Srinivasan\u00a0R (2015) Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies. Clin Ophthalmol 9:393\u2013397","journal-title":"Clin Ophthalmol"},{"key":"1814_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/1756-185X.12688","volume":"20","author":"R Watanabe","year":"2017","unstructured":"Watanabe\u00a0R, Ishii\u00a0T, Yoshida\u00a0M et\u00a0al (2017) Ulcerative keratitis in patients with rheumatoid arthritis in the modern biologic era: a\u00a0series of eight cases and literature review. Int J Rheum Dis 20:225\u2013230","journal-title":"Int J Rheum Dis"},{"key":"1814_CR31","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(04)17554-5","volume":"364","author":"P Mccluskey","year":"2004","unstructured":"Mccluskey\u00a0P, Powell\u00a0RJ (2004) The eye in systemic inflammatory diseases. Lancet 364:2125\u20132133","journal-title":"Lancet"},{"key":"1814_CR32","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/rheumatology\/kem173","volume":"46","author":"RR Sivaraj","year":"2007","unstructured":"Sivaraj\u00a0RR, Durrani\u00a0OM, Denniston\u00a0AK et\u00a0al (2007) Ocular manifestations of systemic lupus erythematosus. Rheumatology 46:1757\u20131762","journal-title":"Rheumatology"},{"key":"1814_CR33","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaophthalmol.2015.2249","volume":"133","author":"K Gallagher","year":"2015","unstructured":"Gallagher\u00a0K, Viswanathan\u00a0A, Okhravi\u00a0N (2015) Association of systemic lupus erythematosus with uveitis. JAMA Ophthalmol 133:1190\u20131193","journal-title":"JAMA Ophthalmol"},{"key":"1814_CR34","doi-asserted-by":"publisher","first-page":"522","DOI":"10.5301\/JN.2011.6244","volume":"24","author":"V Baglio","year":"2011","unstructured":"Baglio\u00a0V, Gharbiya\u00a0M, Balacco-Gabrieli\u00a0C et al (2011) Choroidopathy in patients with systemic lupus erythematosus with or without nephropathy. J\u00a0Nephrol 24:522\u2013529","journal-title":"J Nephrol"},{"key":"1814_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10238-017-0479-9","volume":"18","author":"R Dammacco","year":"2018","unstructured":"Dammacco\u00a0R (2018) Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med 18:135\u2013149","journal-title":"Clin Exp Med"},{"key":"1814_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12886-020-01360-w","volume":"20","author":"CS Hsu","year":"2020","unstructured":"Hsu\u00a0CS, Hsu\u00a0CW, Lu\u00a0MC et al (2020) Risks of ophthalmic disorders in patients with systemic lupus erythematosus\u2014a\u00a0secondary cohort analysis of population-based claims data. BMC Ophthalmol 20:96","journal-title":"BMC Ophthalmol"},{"key":"1814_CR37","unstructured":"Anonymous (2010) Berufsverband der Augen\u00e4rzte Deutschlands e.v. und Deutsche Ophthalmologische Gesellschaft: Leitlinie Nr.\u00a014a Uveitis anterior."},{"key":"1814_CR38","unstructured":"Anonymous (2017) Berufsverband der Augen\u00e4rzte Deutschlands und Deutsche Ophthalmologische Gesellschaft: lietlinie Nr.\u00a024b Nichtinfekti\u00f6se Uveitis posterior."},{"key":"1814_CR39","unstructured":"Anonymous (2021) Berufsverband der Augen\u00e4rzte Deutschlands und Deutsche Ophthalmologische Gesellschaft:Leitlinie Nr.\u00a024a Uveitis intermedia."},{"key":"1814_CR40","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/a-0590-4546","volume":"235","author":"D Doycheva","year":"2018","unstructured":"Doycheva\u00a0D, Deuter\u00a0C, Grajewski\u00a0R (2018) Topical corticosteroids and non-steroidal anti-inflammatory drugs in the therapy of non-infectious uveitis. Klin Monbl Augenheilkd 235:586\u2013591","journal-title":"Klin Monbl Augenheilkd"},{"key":"1814_CR41","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s10792-021-01763-8","volume":"41","author":"U Pleyer","year":"2021","unstructured":"Pleyer\u00a0U, Neri\u00a0P, Deuter\u00a0C (2021) New pharmacotherapy options for noninfectious posterior uveitis. Int Ophthalmol 41:2265\u20132281","journal-title":"Int Ophthalmol"},{"key":"1814_CR42","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1055\/a-0596-7593","volume":"235","author":"T Ness","year":"2018","unstructured":"Ness\u00a0T (2018) Systemic corticosteroids in non-infectious uveitis. Klin Monbl Augenheilkd 235:592\u2013596","journal-title":"Klin Monbl Augenheilkd"},{"key":"1814_CR43","unstructured":"Anonymous (2021) DOG und GKJR Interdisziplin\u00e4re Leitlinie zur Diagnostik und antientz\u00fcndlichen Therapie der Uveitis bei juveniler idiopathischer Arthritis S2K LL Stand 05\/2021."},{"key":"1814_CR44","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00417-018-4082-x","volume":"256","author":"MM Zu Hoerste","year":"2018","unstructured":"Zu Hoerste\u00a0MM, Walscheid\u00a0K, Tappeiner\u00a0C et al (2018) The effect of methotrexate and sulfasalazine on the course of HLA-B27-positive anterior uveitis: results from a\u00a0retrospective cohort study. Graefes Arch Clin Exp Ophthalmol 256:1985\u20131992","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1814_CR45","doi-asserted-by":"crossref","unstructured":"Deutsche Ophthalmologische Gesellschaft, Berufsverband der Augen\u00e4rzte Deutschlands (2017) Leitlinie Nr.\u00a024b der DOG und BVA. Ophthalmologe 114:1122\u20131134","DOI":"10.1007\/s00347-017-0582-z"},{"key":"1814_CR46","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.3346\/jkms.2019.34.e278","volume":"34","author":"S Lee","year":"2019","unstructured":"Lee\u00a0S, Park\u00a0YJ, Lee\u00a0JY (2019) The effect of tumor necrosis factor-alpha inhibitors on Uveitis in patients with ankylosing spondylitis. J\u00a0Korean Med Sci 34:e278","journal-title":"J Korean Med Sci"},{"key":"1814_CR47","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1097\/IAE.0000000000001690","volume":"38","author":"M Mesquida","year":"2018","unstructured":"Mesquida\u00a0M, Molins\u00a0B, Llorenc\u00a0V et al (2018) Twenty-four month follow-up of tocilizumab therapy for refractory uveitis-related macular edema. Retina 38:1361\u20131370","journal-title":"Retina"},{"key":"1814_CR48","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3899\/jrheum.160908","volume":"44","author":"E Quesada-Masachs","year":"2017","unstructured":"Quesada-Masachs\u00a0E, Caballero\u00a0CM (2017) Subcutaneous tocilizumab May be less effective than intravenous tocilizumab in the treatment of juvenile idiopathic arthritis-associated uveitis. J\u00a0Rheumatol 44:260\u2013261","journal-title":"J Rheumatol"},{"key":"1814_CR49","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1002\/art.27581","volume":"62","author":"CM Deuter","year":"2010","unstructured":"Deuter\u00a0CM, Zierhut\u00a0M, Mohle\u00a0A et al (2010) Long-term remission after cessation of interferon-alpha treatment in patients with severe uveitis due to Behcet\u2019s disease. Arthritis Rheum 62:2796\u20132805","journal-title":"Arthritis Rheum"},{"key":"1814_CR50","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ajo.2013.05.002","volume":"156","author":"F Mackensen","year":"2013","unstructured":"Mackensen\u00a0F, Jakob\u00a0E, Springer\u00a0C et\u00a0al (2013) Interferon versus methotrexate in intermediate uveitis with macular edema: results of a\u00a0randomized controlled clinical trial. Am J Ophthalmol 156:478\u2013486.e1","journal-title":"Am J Ophthalmol"},{"key":"1814_CR51","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s10067-019-04875-w","volume":"39","author":"E Miserocchi","year":"2020","unstructured":"Miserocchi\u00a0E, Giuffre\u00a0C, Cornalba\u00a0M et al (2020) JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis. Clin Rheumatol 39:847\u2013851","journal-title":"Clin Rheumatol"},{"key":"1814_CR52","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/acr2.11139","volume":"2","author":"AA Deodhar","year":"2020","unstructured":"Deodhar\u00a0AA, Miceli-Richard\u00a0C, Baraliakos\u00a0X et al (2020) Incidence of uveitis in secukinumab-treated patients with ankylosing spondylitis: pooled data analysis from three phase 3 studies. ACR Open Rheumatol 2:294\u2013299","journal-title":"ACR Open Rheumatol"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01814-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-023-01814-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01814-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T21:06:34Z","timestamp":1675544794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-023-01814-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1814"],"URL":"https:\/\/doi.org\/10.1007\/s00347-023-01814-8","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"25 January 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>I.\u00a0K\u00f6tter<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: AbbVie, Boehringer Ingelheim, Chugai, Celgene, Janssen, GSK, Lilly, Medac, MSD, Novartis, Pfizer, Roche, Sobi. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Chef\u00e4rztin Asklepios Klinik Altona 03\/2014 bis 09\/2019; Direktorin Klinikum Bad Bramstedt und Leiterin Sektion Rheumatologie und Entz\u00fcndliche Systemerkrankungen am UKE Hamburg seit 01.10.2019 | Mitgliedschaften: BDRH, DGRH (Beirat), International Society for Beh\u00e7et\u2019s Disease (Beirat), Mitglied ACR, Deutsche Gesellschaft f\u00fcr Immunologie, Wiss. Kuratorium der Rheumatologischen Fortbildungsakademie, Vorsitzende Kooperatives Rheumazentrum Hamburg. <b>N.\u00a0St\u00fcbiger<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar: Firmen AbbVie, Allergan, Santen, Visufarma, Selbsthilfegruppe Uveitis e.\u202fV.; Referentenhonorar und Erstattung Reisekosten: Firmen Alimera, Novartis; Kostenerstattung: Firma Bayer.\u00a0\u2013 Bezahlter Berater\/interner Schulungsreferent\/Gehaltsempf\u00e4nger o.\u202f\u00c4.: Firma Biogen: Erstellung einer Patientenbrosch\u00fcre zum Thema Uveitis. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellte Ophthalmologin, Augenklinik, Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE) | Mitgliedschaften: Berufsverband f\u00fcr Augen\u00e4rzte (BVA), Dt. Ophthalmologische Gesellschaft (DOG), DOG-Sektion Uveitis, International Uveitis Study Group (IUSG). <b>S.\u00a0Farrokhi<\/b>: A.\u00a0Finanzielle Interessen: S.\u00a0Farrokhi gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Dr. Sanaz Farrokhi, FEBO, Fach\u00e4rztin f\u00fcr Augenheilkunde, t\u00e4tig in der Klinik und Poliklinik f\u00fcr Augenheilkunde am Universit\u00e4tsklinikum Hamburg-Eppendorf | Mitgliedschaften: American Academy of Ophthalmology, \u00d6sterreichische ophthalmologische Gesellschaft, European Society of Cataract and Refractive Surgery, Deutsche Ophthalmologische Gesellschaft. <b>Y.\u00a0Gkanatsas<\/b>: A.\u00a0Finanzielle Interessen: Y.\u00a0Gkanatsas gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Arzt in Weiterbildung, UK Eppendorf Hamburg\/Bad Bramstedt. <b>C.\u00a0Deuter<\/b>: A.\u00a0Finanzielle Interessen: Verg\u00fctung f\u00fcr klinische Studie: Ursapharm, Panoptes, Tarsier.\u00a0\u2013 Vortragshonorare: Novartis, Santen, Th\u00e9a, AbbVie, Amgen, UCB. \u2013\u00a0Beratert\u00e4tigkeit: Alimera.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: T\u00e4tigkeit: Universit\u00e4tsklinikum T\u00fcbingen, Department f\u00fcr Augenheilkunde (Oberarzt) | Mitgliedschaften: Deutsche Ophthalmologische Gesellschaft (DOG), Berufsverband der Augen\u00e4rzte Deutschlands (BVA).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}